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ABSTRACT
This study evaluated the validity of bone marrow (BM) and blood specimens for the diagnosis of
disseminated mycobacterial infections (DMIs). From 1990 to February 1997, all specimens were
processed with the lysis–centrifugation procedure; thereafter (until December 2001), they were processed
with the BACTEC Myco ⁄F Lytic system. Twenty-three paired BM–blood specimens with mycobacteria
in at least one specimen were studied from 23 patients. The strains isolated were 14 Mycobacterium avium
complex (MAC) and nine M. tuberculosis complex (MTBC). Blood specimens had a statistically
significant greater sensitivity for the isolation of MAC than BM (100% vs. 57.1%, respectively), whereas
sensitivity for the isolation of MTBC was equal for the two specimen types (66.7%). Although not
statistically significant, the times required to detect mycobacteria from blood specimens were lower than
those from BM in the MycoF ⁄Lytic system. Overall, blood cultures represented a more sensitive and less
invasive alternative to BM cultures for the diagnosis of disseminated mycobacteriosis caused by MAC,
especially when the MycoF ⁄Lytic system was used, but provided no advantage for the diagnosis of DMI
caused by MTBC.
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INTRODUCTION
Diagnosis of disseminated mycobacterial infec-
tion (DMI) can be achieved by the use of several
histopathological and ⁄ or microbiological criteria,
including the recovery of mycobacteria from
bone marrow (BM) and blood specimens [1–4].
Although blood extraction is less invasive than
BM aspiration, little is known about the useful-
ness of blood culture compared with BM culture
for the evaluation of patients with suspected
DMI [3,5–7]. Therefore, the objective of the
present study was to compare the microbiologi-
cal yields of concurrently obtained BM and
blood cultures for the diagnosis of DMI in
patients admitted to our institution over a
12-year period.
MATERIALS AND METHODS
Patients
All BM and blood specimens sent to the mycobacteriology
laboratory of the Hospital General Universitario Gregorio
Maran˜o´n (Madrid, Spain) from patients suspected of having
DMI during the period 1990–2001 were analysed retrospec-
tively. Specimens with contaminated cultures were excluded
from the study. All pairs of BM–blood specimens from the
same patient were included in the study, provided that there
was a maximum of 10 days between the two specimens being
taken. The clinical charts of all patients included in the study
were reviewed for empirical or prophylactic anti-mycobacte-
rial therapies in the period from 1 month before the first
specimen or between specimens.
Staining procedures
BM smears were taken on glass slides by the haematologist at
the bedside and were sent to the laboratory with culture
specimens. They were then stained by the auramine technique.
Blood samples were not stained.
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Cultures and identification
From January 1990 to February 1997, BM and blood specimens
were processed by lysis–centrifugation [8], using Lowenstein–
Jensen medium (with and without pyruvate) and Middlebrook
7H9 broth as culture media. Briefly, 8–10 mL of blood was
inoculated into an average of three BACTEC PLUS Aerobic ⁄ F*
bottles (Becton Dickinson, Sparks, MD, USA). After the bottles
had been incubated at 35C for 5 days in the BACTEC 9000
instrument (Becton Dickinson), 10 mL of Middlebrook 7H9
broth was added to bottles which showed no apparent growth.
The bottles were then incubated for a further 7 days. After this
second incubation period, 10 mL from each bottle for the same
patient was transferred to a tube containing 0.5 mL of sodium
deoxycholate (0.1 g ⁄mL). Following centrifugation at 3800 g
for 15 min, the leukocyte layer was inoculated finally on to
culture media.
BM specimens (c. 2–5 mL) were transferred into glass tubes
containing glass beads and vortexed for 10 min. They were
then centrifuged at 3800 g for 15 min, followed by inoculation
of the sediments on to culture media. For both blood
specimens and BM, the media were incubated in an aerobic
atmosphere at 37C for 8 weeks, or until positive growth was
observed. Cultures were examined on a weekly basis.
During the second period (February 1997 onwards), both
specimen types were cultured in MycoF ⁄Lytic bottles (Becton
Dickinson) according to standard procedures [8].
Presumptive mycobacterial identification
Isolates were identified using DNA probes (AccuProbe;
GenProbe, San Diego, CA, USA) according to the manufac-
turer’s instructions.
Data analysis
Sensitivity rates were calculated with reference to the growth
of mycobacteria in any type of specimen. The recovery rates of
mycobacteria from both types of specimen were compared by
the exact binomial test for paired samples [9]. The median
times required for detection by the two culture systems, both
globally and by species, were compared with the Mann–
Whitney test. In order to allow for the weekly reading of the
cultures, the time required for growth of mycobacteria was
calculated from the day when samples were first processed in
the laboratory until 3 days before growth was first observed.
The median times required for detection of both types of
specimen were compared by the Wilcoxon signed-rank test for
paired specimens [10]. A p value £ 0.05 was considered to be
statistically significant.
RESULTS
During the study period (1990–2001), 7237 blood
specimens were taken from 4759 patients (average
number ⁄patient = 1.5), and 1238 BM specimens
from 1076 patients were sent to the mycobacteri-
ology laboratory. Of these, 388 paired BM–blood
specimens from 356 patients fulfilled the criterion
for selection (i.e., a maximum of 10 days between
the two specimens). Forty-four pairs of specimens
(11.3%) from 42 different patients grew mycobac-
teria from at least one specimen. However,
21 pairs from 19 patients were excluded from
the study because the patients had received anti-
mycobacterial drugs in the previous month or
between the two specimens being taken. There-
fore, 23 pairs of specimens from different patients
remained for analysis. Blood specimens were
taken before BM specimens in 18 patients
(78.3%; median time, 6 days), two were taken
after (8.7%; median time, 3 days), and the
remaining three pairs were taken on the same
day. The mycobacterial strains isolated from the
23 patients comprised 14 Mycobacterium avium
complex (MAC) and nine M. tuberculosis complex
(MTBC). Smears were taken for all 23 BM sam-
ples, but these showed a sensitivity of only 8.7%,
with only two positive results. No single episode
was produced by more than one strain. All but
four patients (all MTBC isolates) were HIV-pos-
itive.
When the pairs of specimens from the
23 patients were analysed, 11 were positive for
both MAC and MTBC (eight MAC and three
MTBC isolates), BM grew only three (all MTBC),
and blood grew only nine (six MAC and three
MTBC). Global sensitivities for the recovery of all
species were 60.9% from BM and 87.0% from
blood (not significant) (Table 1). These differences
were greater when compared with those pairs
from patients suffering from MAC infection (57.1
and 100%, respectively; p 0.03). However, in pairs
from patients with disseminated tuberculosis,
Table 1. Rates of recovery of mycobacteria from BM and
blood cultures for the 23 patients analysed
Isolates
Number of positive specimens
Lysis–centrifugation
1990–1997
MycoF/Lytic
1997–2001a Total
All
Total 15 8 23
BM 10 (66.7%) 4 (50%) 14 (60.9%)
Blood 14 (93.3%) 6 (75%) 20 (87.0%)
MAC
Total 11 3 14
BM 7 (70.0%) 1 (33.3%) 8 (57.1%)
Blood 11 (100%) 3 (100%) 14 (100%)
MTBC
Total 4 5 9
BM 3 (75.0%) 3 (60%) 6 (66.7%)
Blood 3 (75.0%) 3 (60%) 6 (66.7%)
aThere were no statistically significant differences between the rates of recovery of
mycobacteria from BM and blood specimens globally, during each period and by
species, except for MAC during the entire period.
BM, bone marrow; MTB, Mycobacterium avium complex; MTBC, M. tuberculosis
complex.
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both specimens had the same sensitivity (66.7%).
These recovery rates were similar in each period
studied.
When the median times required for detection
of mycobacteria by both systems were compared
(Table 2), the MycoF ⁄Lytic system recovered my-
cobacterial isolates earlier from both types of
specimen, but the differences were only statisti-
cally significant for blood cultures. When the
median time required for detection of mycobac-
teria from BM vs. blood cultures was analysed
using the data for the 11 paired specimens that
both grew mycobacteria, there were no statisti-
cally significant differences between the values.
However, blood cultures processed by the My-
coF ⁄Lytic system revealed mycobacteria in
approximately half the time needed for BM.
DISCUSSION
DMIs are serious illnesses with a fatal outcome in
the absence of treatment. For this reason, prompt
diagnosis is essential in the management of DMI.
Moreover, isolation of mycobacteria from affected
organs or tissue is required for a definitive
diagnosis. Traditionally, BM has been an efficient
tissue specimen for the diagnosis of DMI,
although invasive procedures are necessary to
obtain specimens [2,4,5,11,12]. Therefore, blood
culture could represent an alternative for the
diagnosis of this illness. The present study com-
pared the usefulness of BM and blood cultures for
the diagnosis of DMI over a 12-year period.
To our knowledge, only four studies have
performed a parallel evaluation of the diagnostic
yields of blood and BM cultures in DMI, using
either solid media (Lowenstein–Jensen and ⁄ or
Middlebrook 7H11 agar) [3,5–7], 7H12 Bactec
vials [5,7], or other liquid media [6,7]. In the
present study, two different culture systems were
used for the recovery of mycobacteria during the
study period. A lysis–centrifugation procedure,
with Lowenstein–Jensen pyruvate and Middle-
brook 7H9 media as the final culture media, was
performed during the first part of the study, after
which the MycoF ⁄Lytic system was used. The
global sensitivity of blood culture in the present
study (87.0%) was similar to that reported earlier
(62–83%), but the global sensitivity of BM culture
(60.9%) was lower than reported elsewhere
(78–93%) [3,5–7]. As some patients took anti-
mycobacterial drugs before specimen extraction
in at least one previous study [3] (no information
was available from the other studies), a higher
sensitivity might have been expected in the
present study. However, other variables, such as
the time between the two specimens being taken
(6 weeks [3], 2 weeks [6], 3 days [5], unspecified
[7]), the number of pairs, the mycobacterial
species isolated and the processing method used,
could explain these differences.
The low number of cases included in some data
comparisons in the study made statistical analysis
difficult. However, differences in sensitivity were
observed between BM and blood cultures for
paired specimens that grew MAC isolates, espe-
cially during the MycoF ⁄Lytic period. In contrast,
there were no differences when comparing paired
specimens that yielded MTBC. It is not known
whether two sets of blood cultures have a greater
diagnostic yield for the isolation of MTBC than
only one set. Unfortunately, the three patients
(two of whom were HIV-positive) diagnosed with
disseminated tuberculosis infections only on the
basis of positive BM cultures did not have other
simultaneous blood cultures taken, although one
patient had a positive blood culture taken 18 days
before the extraction of the BM specimen.
The results showed that the MycoF ⁄Lytic sys-
tem was generally faster than lysis–centrifugation
for both types of specimen, whether for MAC or
MTBC isolates, with a decrease in median time
required for detection of 33.5–22 days (decreasing
average, 34%; range, 7–62%). A previous study
performed with blood specimens showed a
reduction in the time required for diagnosis of
61% [8]. Other studies have shown the utility of
the MycoF ⁄Lytic system for the diagnosis of DMI
Table 2. Time required for detection of mycobacteria from
bone marrow and blood cultures for the 23 patients
analysed
Isolates
Number (range) of days required for detection of mycobacteria
Lysis–centrifugation
1990–1997
MycoF/Lytic
1997–2001a Total
All
BM 27 (18–60) 23.5 (12–35) 26 (12–60)
Blood 37.5 (20–70) 17.5 (11–28) 31.5 (11–70)
MAC
BM 27 (18–60) 25 26 (18–60)
Blood 40 (26–70) 22 (12–28) 30.5 (12–70)
MTBC
BM 31 (25–36) 22 (12–35) 28.5 (12–36)
Blood 34 (20–52) 13 (11–26) 23 (11–52)
aThere were no statistically significant differences between the median times to
detection of mycobacteria by both systems, either globally or by species, except for
blood specimens during the entire period (p 0.001) and for the isolation of MAC
(p 0.019).
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from blood specimens, whether for MAC infec-
tions (median time range, 10–16 days) [8,13,14] or
MTBC infections (median time range, 19–26 days)
[8,15]. When positive paired specimens were
analysed, the MycoF ⁄ lytic system detected myco-
bacteria from blood specimens in about half the
time required for BM. Although smears from BM
could provide a rapid presumptive diagnosis of
DMI, the study showed a low sensitivity for this
technique.
In summary, blood culture represents a more
sensitive and less invasive procedure than BM
culture for the diagnosis of DMI caused by MAC
isolates, especially when using the MycoF ⁄Lytic
system. In this respect, a single blood culture
using the MycoF ⁄Lytic system could be the first
step in the diagnosis of DMI caused by MAC.
However, sensitivity was similar for the recovery
of MTBC strains, so one-third of the episodes
would have been misdiagnosed without the BM
culture. The use of BM and blood cultures in
combination would provide the maximum sensi-
tivity for diagnosis of disseminated tuberculous
infections.
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